Structure | Chemical Name | CAS | MF |
|
VDD protocol
|
|
|
|
V.C.N.T. for Thayer Martin Medium
|
|
|
|
VCN SUPPLEMENT
|
|
|
|
VCPC protocol
|
|
|
|
Vc-Pmg
|
|
|
|
VCP protocol 2
|
|
|
|
vcp41 protein
|
|
|
|
vcp42 protein
|
|
|
|
VCP1 serine protease
|
|
|
|
VCRC-INS-A-23
|
98227-54-4
|
|
|
VE
|
18920-62-2
|
C29H50O2
|
|
VE510
|
|
|
|
VE802
|
|
|
|
VCS 257 E COLI STRAIN (CONTROL)
|
|
|
|
VCRP protocol
|
|
|
|
VCSM13 INTERFERENCE-RESISTANT HELPER PHAGE
|
|
|
|
VCSP protocol
|
|
|
|
VDJ recombinase
|
|
|
|
VEBAB66
|
|
|
|
VEBAB68
|
|
|
|
VEBAB31
|
|
|
|
VEAL
|
|
|
|
VEAL INFUSION BROTH
|
|
|
|
VEBEP regimen
|
|
|
|
VDM13
|
|
C31H46N2O
|
|
Vear protein
|
|
|
|
VECABOP protocol
|
|
|
|
VE-Cadherin Polyclonal Antibody
|
|
|
|
VE calcium succinate
|
|
|
|
VDL protein
|
|
|
|
VEDACLIDINE
|
141593-42-2
|
C13H21N3S2
|
|
Vedaclidine
|
141575-50-0
|
C13H21N3S2
|
|
Vebufloxacin
|
79644-90-9
|
C19H22FN3O3
|
|
Vedaprofen impurity mixture
|
|
|
|
Vedaprofen VETRANAL
|
|
|
|
Vedaprofen-d3 VETRANAL
|
|
|
|
Vedaprofen-d3
|
1185054-34-5
|
C19H22O2
|
|
VEDAPROFEN
|
|
C19H22O2
|
|
VECTABOND(TM) REAGENT
|
|
|
|
VECTOMER 2010 VINYL ETHER
|
143477-68-3
|
|
|
VECTOMER 2020 VINYL ETHER
|
143477-70-7
|
|
|
Vectors, Cloning Applications: Essential Techniques Series
|
|
|
|
VectorizedWheatAminoAcids
|
|
|
|
VectorizedGlycine
|
|
|
|
VectorizedOatProteinAminoAcids
|
|
|
|
VectorizedProline
|
|
|
|
VectorizedHydroxypropline
|
|
|
|
VECTRACELL(TM)
|
|
|
|
VECTREX(R) AVIDIN D
|
|
|
|
VECTRASE-P
|
|
|
|
Ethanol
|
64-17-5
|
C2H6O
|
|
VECTREX(R) AVIDIN DLA
|
|
|
|
VECTRAZYME-PAP
|
|
|
|
VECTRASE CD
|
|
|
|
VECTRASYNTH
|
|
|
|
VECUNI HIGH TITER VIRUS STOCK
|
|
|
|
VECUNI BACULOVIRUS DNA
|
|
|
|
vecuroniuM broMide
|
|
|
|
Vecuronium Bromide Related Compound F (15 mg) (Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-17-acetyloxy-3-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide)
|
|
|
|
Vecuronium Bromide Related Compound B (15 mg) (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide)
|
|
|
|
Vecuronium Bromide Related Compound C (15 mg) [Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-dihydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide]
|
|
|
|
Vecuronium Bromide Related Compound A (25 mg) (3alpha, 17beta-diacetyl-oxy-2beta, 16beta-bispiperidinyl-5alpha-androstan)
|
|
|
|
Vecuronium Bromide (50 mg)
|
|
|
|
Vecuronium Bromide for Injection
|
|
|
|
Vecuronium bromide
|
50700-72-6
|
C34H57BrN2O4
|
|
VECURONIUMBROMIDE
|
|
|
|
VECURONIUM BROMIDE''S INTERMEDIATES
|
|
|
|
VCX protein
|
|
|
|
VEEGUM
|
1327-43-1
|
Al2F30Mg2Si5
|
|
VD3 oil ,Cholecalciferol
|
8024-19-9
|
C27H44O
|
|
VEEP regimen
|
|
|
|
VCY protein
|
|
|
|
Vegadex-d10
|
|
C8H14ClNS2
|
|
VEGANDIETSTUDIES
|
|
|
|
VEGANDIET
|
|
|
|
VEGANS
|
|
|
|
VegA protein
|
|
|
|
Vega1 protein
|
|
|
|
VEGAREDALKALINEPHOSPHATASE(ALP)CHROMOGEN(XYLENECOMP.)KIT
|
|
|
|
Vegfa protein, human
|
205887-54-3
|
C13H20ClNOS
|
|
VEGF Accucyte(R) EIA Kit, Human
|
|
|
|
VEGF-B PRIMER PAIR
|
|
|
|
VEGF-C Polyclonal Antibody
|
|
|
|
VEGF-C (Vascular Endothelial Growth Factor C)
|
|
|
|
VEGF-C PRIMER PAIR
|
|
|
|
VEGF121-diphtheria toxin conjugate
|
|
|
|
VEGF-D (Vascular Endothelial Growth Factor D, c-fos induced growth factor, FIGF)
|
|
|
|
VEGF-D Polyclonal Ab
|
|
|
|
VEGF-D PRIMER PAIR
|
|
|
|
VEGF ELISA Kit, Human
|
|
|
|
VEGF ELISA Kit, Mouse
|
|
|
|
VEGF/FITC
|
|
|
|
VEGF Inhibitor, Je-11
|
|
|
|
VEGF(IHC dilution: 1:100)
|
|
|
|
VEGF Inhibitor, CBO-P11
|
|
|
|
VEGF(IHC dilution: Ready-to-use)
|
|
|
|
vegetable oil acid
|
|
|
|
Vegetable fatty acids
|
61788-66-7
|
|
|
VEGETARIAN RENNET.
|
|
|
|
VEGETABLE BOUILLON & LOW SALT OPTION
|
|
|